GMP testing

GMP testing comprises those stages of drug development when an investigational drug becomes a pharmaceutical drug. ‘A drug prototype’ should be administered to human individuals in clinical trial phases II and III.

If a candidate drug was successfully confirmed in clinical trials and its manufacturing is approved, QM/batch release protocols may include DNA/RNA-based methods and/or cell techniques.

The GMP methods we offer are specialized in DNA/RNA technology and/or cell techniques. They are required for QM/batch release in the field of gene therapy, biomolecules drugs such as vaccines and proteins.